Natco Pharma Annual Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2023	Mar-2022	Mar-2021	Mar-2020	Mar-2019
Gross Sales	2707.10	1944.80	2052.10	1,915	2094.50
Excise Duty	--	--	--	--	--
Net Sales	2707.10	1944.80	2052.10	1,915	2094.50
Other Operating Income	--	--	--	--	--
Other Income	104.60	99	103.60	107.40	130.20
Total Income	2811.70	2043.80	2155.70	2022.40	2224.70
Total Expenditure	1771.50	1681.30	1445.90	1332.40	1299.70
PBIDT	1040.20	362.50	709.80	690	925
Interest	14.50	17.70	13.30	21.50	19.30
PBDT	1025.70	344.80	696.50	668.50	905.70
Depreciation	163.80	142.60	116.90	99.80	81
Minority Interest Before NP	--	--	--	--	--
Tax	162.70	47.80	147.80	131.10	188.30
Deferred Tax	(16.10)	(15.60)	(10.60)	(20.50)	(6)
Reported Profit After Tax	715.30	170	442.40	458.10	642.40
Minority Interest After NP	--	--	1.50	(2.70)	(2)
Net Profit after Minority Interest	715.30	170	440.90	460.80	644.40
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	715.30	170	440.90	460.80	644.40
EPS (Unit Curr.)	39.18	9.32	24.20	25.33	34.98
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	275	225	262.50	337.50	312.50
Equity	36.50	36.50	36.50	36.40	36.50
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	38.42	18.64	34.59	36.03	44.16
PBDTM(%)	37.89	17.73	33.94	34.91	43.24
PATM(%)	26.42	8.74	21.56	23.92	30.67

QuickLinks for Natco Pharma Ltd.